Abstract
Oligodendrocytes are implicated in amyotrophic lateral sclerosis pathogenesis and display transactive response DNA-binding protein-43 (TDP-43) pathological inclusions. To investigate the cell autonomous consequences of TDP-43 mutations on human oligodendrocytes, we generated oligodendrocytes from patient-derived induced pluripotent stem cell lines harbouring mutations in the TARDBP gene, namely G298S and M337V. Through a combination of immunocytochemistry, electrophysiological assessment via whole-cell patch clamping, and three-dimensional cultures, no differences in oligodendrocyte differentiation, maturation or myelination were identified. Furthermore, expression analysis for monocarboxylate transporter 1 (a lactate transporter) coupled with a glycolytic stress test showed no deficit in lactate export. However, using confocal microscopy, we report TDP-43 mutation-dependent pathological mis-accumulation of TDP-43. Furthermore, using in vitro patch-clamp recordings, we identified functional Ca2þpermeable a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor dysregulation in oligodendrocytes. Together, these findings establish a platform for further interrogation of the role of oligodendrocytes and cellular autonomy in TDP-43 proteinopathy.
Original language | English |
---|---|
Article number | fcab255 |
Number of pages | 12 |
Journal | Brain Communications |
Volume | 3 |
Issue number | 4 |
Early online date | 26 Oct 2021 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
AcknowledgementsThe authors kindly acknowledge the technical expertise and
assistance of Ms Nicola Miller and Ms Karen Gladstone.
Graphical abstract was created using BioRender.com.
Funding
This research was supported by the Wellcome Trust
(092742/Z/10/Z), MND Association (Miles/Oct14/878–
792), SC lab is supported by the Euan MacDonald Centre
for Motor Neurone Disease Research, and the UK Dementia
Research Institute (DRI), which receives its funding from UK
DRI Ltd, funded by the MRC, Alzheimer’s Society and
Alzheimer’s Research UK. SC also acknowledges funding
from the ARRNC, Department of Biotechnology India,
University of Edinburgh Institutional Strategic Support Fund.
Royal Society of Edinburgh (M.R.L), WT NIA 100981/Z/
13/Z (N.M.M.), ARRNC (B.T.S) and an Australian
National Health and Medical Research (NH&MRC) and
Australian Research Council (ARC) Dementia Research
Development Fellowship (S.K.B.: 1110040)
Keywords
- amyotrophic lateral sclerosis
- oligodendrocytes
- TDP-43
- induced pluripotent stem cell